Hepatitis B and Hepatitis C Virus Replication Upregulates Serine Protease Inhibitor Kazal, Resulting in Cellular Resistance to Serine Protease-Dependent Apoptosis -- Lamontagne et al. 84 (2): 907 Data Supplement - Supplemental material -- The Journal of Virology

Hepatitis B and Hepatitis C Virus Replication Upregulates Serine Protease Inhibitor Kazal, Resulting in Cellular Resistance to Serine Protease-Dependent Apoptosis
J. Virol. Lamontagne et al. 84: 907

Supplemental material

Files in this Data Supplement:

Supplemental file 1 - Fig. S1 (Double staining with anti-HBsAg and annexin-V suggests that most of the HBsAg positive cells were negative for apoptosis.)
Fig. S2 (Ribavirin treatments have no effect on SPIK levels and cellular resistance to apoptosis.)
Fig. S3 (Specificity of SPIK siRNA and HBV siRNA.)
Word file, 736K.